Data coverage, completeness and provenance for NOVA EYE MEDICAL LIMITED in the Stock Market API — Health Care · Medical Devices.
Source date: 2026-10-30T02:39:14. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.1500 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.1500 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.1500 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.1600 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.1500 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/EYE/prices · Price parameters and adjustment semantics
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company operates through Glaucoma Surgical Devices and AlphaRET segments. It offers 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma; iTrack Advance; and Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Website: https://www.nova-eye.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/EYE/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 30 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 30 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 29 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 29 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 27 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/EYE
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/EYE/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/EYE/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/EYE/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/EYE/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/EYE
Free tier — instant API key. Built for AI agents.